Updated Results From Destiny-Breast01, A Phase 2 Trial Of Trastuzumab Deruxtecan (T-Dxd) In Her2 Positive Metastatic Breast Cancer

CANCER RESEARCH(2021)

Cited 6|Views16
No score
Key words
positive metastatic destiny-breast01 cancer,destiny-breast01 cancer,trastuzumab,t-dxd
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined